Benitec Biopharma Inc. (BNTC) stock
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.15−0.39 (-4.57%)
Close on Nov 17, 2026Market cap $284.29MP/E –Yield –
Benitec Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Benitec Biopharma's price to book ratio was 1.8× on Nov 11, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 1.4× to 134.7×, with a median of 4.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.8× | −1.9 |
| 2025 | Dec 31, 2025 | 3.8× | −12.1 |
| 2024 | Dec 31, 2024 | 15.8× | +14.2 |
| 2023 | Dec 29, 2023 | 1.7× | −21.3 |
| 2022 | Dec 30, 2022 | 23.0× | −82.9 |
| 2021 | Dec 31, 2021 | 105.8× | +73.0 |
| 2020 | Dec 31, 2020 | 32.9× | +2.7 |
| 2019 | Dec 31, 2019 | 30.2× | – |
See a number that looks wrong?